Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.
Delaware Growth and Income A FGINX
- NAV / 1-Day Return 14.91 / −0.74 %
- Total Assets 1.1 Bil
-
Adj. Expense Ratio
- Expense Ratio 1.020%
- Distribution Fee Level Average
- Share Class Type Front Load
- Category Large Value
- Investment Style Large Value
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 2.05%
- Turnover 26%
USD | NAV as of May 03, 2024 | 1-Day Return as of May 03, 2024, 12:23 AM GMT+0
Morningstar’s Analysis FGINX
Will FGINX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 34.5
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Exxon Mobil Corp | 4.99 | 68.2 Mil | Energy |
Merck & Co Inc | 4.30 | 58.8 Mil | Healthcare |
The Cigna Group | 3.64 | 49.8 Mil | Healthcare |
Cisco Systems Inc | 3.50 | 47.9 Mil | Technology |
Lowe's Companies Inc | 3.34 | 45.6 Mil | Consumer Cyclical |
CVS Health Corp | 3.08 | 42.1 Mil | Healthcare |
Gilead Sciences Inc | 2.99 | 40.9 Mil | Healthcare |
Philip Morris International Inc | 2.99 | 40.8 Mil | Consumer Defensive |
Marathon Petroleum Corp | 2.99 | 40.8 Mil | Energy |
Bristol-Myers Squibb Co | 2.98 | 40.8 Mil | Healthcare |